Resting heart rate and long-term outcomes among the African American population: Insights from the Jackson Heart Study

JAMA Cardiology

Volumn 2, Issue 2, 2017, Pages 172-180

  Parikh, Kishan S ^a   Greiner, Melissa A ^a   Suzuki, Takeki ^b   DeVore, Adam D ^a,c   Blackshear, Chad ^d   Maher, Joseph F ^b   Curtis, Lesley H ^a,c   Hernandez, Adrian F ^a,c   O’Brien, Emily C ^a,c   Mentz, Robert J ^a,c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE;

ADULT; AFRICAN AMERICAN; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; RESTING HEART RATE; SENSITIVITY ANALYSIS; SMOKING; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; ETHNOLOGY; EXERCISE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; MIDDLE AGED; MISSISSIPPI; MORBIDITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; REST; RISK FACTOR; SURVIVAL RATE; TIME FACTOR; TRENDS;

AFRICAN AMERICANS; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MISSISSIPPI; MORBIDITY; PROGNOSIS; PROSPECTIVE STUDIES; REST; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 85020584634     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.3234     Document Type: Article

References (36)

1. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetière P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med. 2005;352(19):1951-1958.
2. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987;113(6):1489-1494.
3. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26(10):967-974.
4. Zhang D, Shen X, Qi X. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ. 2016;188(3): E53-E63.
5. Giannoglou GD, Chatzizisis YS, Zamboulis C, Parcharidis GE, Mikhailidis DP, Louridas GE. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol. 2008;126(3):302-312.
6. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation. 2001;104 (13):1477-1482.
7. Fox K, Borer JS, Camm AJ, et al; Heart Rate Working Group. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50(9):823-830.
8. Böhm M, Swedberg K, Komajda M, et al; SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376(9744): 886-894.
9. US Census Bureau. State and County QuickFacts; 2015. http://quickfacts.census.gov. Accessed November 18, 2015.
10. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(1):30-41.
11. Taylor HA Jr. The Jackson Heart Study: an overview. Ethn Dis. 2005;15(4)(suppl 6):S6-S1, 3.
12. Fuqua SR, Wyatt SB, Andrew ME, et al. Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis. 2005;15(4) (suppl 6):S6-S18, 29.
13. Carpenter MA, Crow R, Steffes M, et al. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci. 2004;328(3):131-144.
14. Keku E, Rosamond W, Taylor HA Jr, et al. Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures. Ethn Dis. 2005;15(4)(suppl 6):S6-S62, 70.
15. Avery CL, Mills KT, Chambless LE, et al. Long-term association between self-reported signs and symptoms and heart failure hospitalizations: the Atherosclerosis Risk In Communities (ARIC) Study. Eur J Heart Fail. 2010;12(3):232-238.
16. Vazir A, Claggett B, Jhund P, et al. Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program. Eur Heart J. 2015;36(11):669-675.
17. Power Transformations by Box-Tidwell. SAS macro programs: boxtid method. http://www.datavis.ca/sasmac/boxtid.html. Published May 15, 2006. Accessed August 29, 2016.
18. Breslow NE, Day NE. Statistical methods in cancer research; volume II—the design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1-406.
19. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706.
20. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer; 2001.
21. SAS/STAT. 9.2 User's Guide, Second Edition. https://support.sas.com/documentation/cdl/en/statug /63033/HTML/default/viewer.htm#statug_phreg _a0000000697.htm. Accessed August 29, 2016.
22. Swedberg K, Komajda M, Böhm M, et al; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376(9744): 875-885.
23. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292.
24. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med. 2001;344(18):1351-1357.
25. Carson P, Ziesche S, Johnson G, Cohn JN; Vasodilator-Heart Failure Trial Study Group. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. J Card Fail. 1999;5(3):178-187.
26. Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344(22):1659-1667.
27. Ishizawar D, Yancy C. Racial differences in heart failure therapeutics. Heart Fail Clin. 2010;6(1):65-74.
28. Greene SJ, Vaduganathan M, Wilcox JE, et al; EVEREST Trial Investigators. The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial. JACC Heart Fail. 2013;1 (6):488-496.
29. Ho JE, Larson MG, Ghorbani A, et al. Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study. J Am Heart Assoc. 2014;3(3):e000668.
30. Khan H, Kunutsor S, Kalogeropoulos AP, et al. Resting heart rate and risk of incident heart failure: three prospective cohort studies and a systematic meta-analysis. J Am Heart Assoc. 2015;4(1):e001364.
31. Laskey WK, Alomari I, Cox M, et al; AHA Get With the Guidelines–Heart Failure Program. Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization. J Am Heart Assoc. 2015;4(4): e001626.
32. Opdahl A, Ambale Venkatesh B, Fernandes VR, et al. Resting heart rate as predictor for left ventricular dysfunction and heart failure: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2014;63(12):1182-1189.
33. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997;29(4):709-715.
34. Palatini P. Heart rate as a cardiovascular risk factor: do women differ from men? Ann Med. 2001; 33(4):213-221.
35. Böhm M, Reil JC, Deedwania P, Kim JB, Borer JS. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med. 2015;128(3):219-228.
36. Böhm M, Schumacher H, Schmieder RE, et al. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies. J Intern Med. 2015;278(1):38-49.